BMO Capital Upgrades Pfizer (PFE) to Outperform

August 2, 2017 6:11 AM EDT Send to a Friend
BMO Capital upgraded Pfizer (NYSE: PFE) from Market Perform to Outperform with a price target of $37.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login